JP2006508061A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508061A5
JP2006508061A5 JP2004537389A JP2004537389A JP2006508061A5 JP 2006508061 A5 JP2006508061 A5 JP 2006508061A5 JP 2004537389 A JP2004537389 A JP 2004537389A JP 2004537389 A JP2004537389 A JP 2004537389A JP 2006508061 A5 JP2006508061 A5 JP 2006508061A5
Authority
JP
Japan
Prior art keywords
phenyl
hydroxy
alkyl
benzyl
benzenesulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004537389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508061A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/003824 external-priority patent/WO2004026823A1/en
Publication of JP2006508061A publication Critical patent/JP2006508061A/ja
Publication of JP2006508061A5 publication Critical patent/JP2006508061A5/ja
Abandoned legal-status Critical Current

Links

JP2004537389A 2002-09-20 2003-09-08 エストロゲン受容体に対するアミドおよびスルホンアミドリガンド Abandoned JP2006508061A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41233802P 2002-09-20 2002-09-20
PCT/IB2003/003824 WO2004026823A1 (en) 2002-09-20 2003-09-08 Amide and sulfonamide ligands for the estrogen receptor

Publications (2)

Publication Number Publication Date
JP2006508061A JP2006508061A (ja) 2006-03-09
JP2006508061A5 true JP2006508061A5 (cg-RX-API-DMAC7.html) 2006-10-05

Family

ID=32030852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004537389A Abandoned JP2006508061A (ja) 2002-09-20 2003-09-08 エストロゲン受容体に対するアミドおよびスルホンアミドリガンド

Country Status (8)

Country Link
US (1) US7053212B2 (cg-RX-API-DMAC7.html)
EP (1) EP1542967A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006508061A (cg-RX-API-DMAC7.html)
AU (1) AU2003263402A1 (cg-RX-API-DMAC7.html)
BR (1) BR0314126A (cg-RX-API-DMAC7.html)
CA (1) CA2499490A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05003054A (cg-RX-API-DMAC7.html)
WO (1) WO2004026823A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265145B2 (en) * 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
WO2005087710A1 (ja) 2004-03-15 2005-09-22 Takeda Pharmaceutical Company Limited アミノフェニルプロパン酸誘導体
US7504431B2 (en) * 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
WO2006042172A2 (en) * 2004-10-09 2006-04-20 The Regents Of The University Of Michigan Gender differences in experimental aortic aneurysm formation
WO2007055374A1 (ja) * 2005-11-14 2007-05-18 Mitsubishi Tanabe Pharma Corporation 骨粗鬆症治療剤
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8158828B2 (en) 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
DE102006013957A1 (de) * 2006-03-27 2007-10-04 Bayer Healthcare Aktiengesellschaft Substituierte N-Benzyl-N-phenylbenzolsulfonamide
KR101638035B1 (ko) 2007-01-22 2016-07-11 지티엑스, 인코포레이티드 핵 수용체에 결합하는 물질
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
GB0711463D0 (en) * 2007-06-14 2007-07-25 Opal Drug Discovery Ltd Trimethylsilylbeneylsulphamates as treatments for diseases of bone loss
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
CN103201279A (zh) 2010-11-05 2013-07-10 赛诺米克斯公司 作为trpm8的调节剂有用的化合物
CN104208069A (zh) 2014-05-08 2014-12-17 上海市计划生育科学研究所 双炔失碳酯组合物和疾病治疗方法
EP3350165B1 (en) 2015-09-16 2023-07-26 Organovo, Inc. Farnesoid x receptor agonists and uses thereof
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
AU2018236275B2 (en) 2017-03-15 2022-05-12 Eli Lilly And Company Farnesoid X receptor agonists and uses thereof
DK3596053T3 (da) 2017-03-15 2023-09-25 Organovo Inc Farnesoid-x-receptoragonister og anvendelser deraf
EP3852748B1 (en) 2018-09-18 2025-09-03 Eli Lilly and Company Farnesoid x receptor agonists and uses thereof
CN109651297B (zh) * 2019-01-22 2022-05-27 杭州壹瑞医药科技有限公司 一种n-苄基-n-芳基磺酰胺类衍生物及制备和应用
JP7664278B2 (ja) 2020-03-18 2025-04-17 オルガノボ,インク. ファルネソイドx受容体アゴニストの結晶質形態
CN120227340A (zh) 2020-03-18 2025-07-01 伊莱利利公司 法尼醇x受体激动剂的制剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US156281A (en) * 1874-10-27 Improvement in wheels for vehicles
DE1122076B (de) * 1955-07-08 1962-01-18 Geigy Ag J R Verfahren zur Herstellung von neuen, therapeutisch wertvollen, insbesondere antiphlogistisch wirksamen N-acylierten Hydroxybenzylaminophenolen
GB811130A (en) * 1955-07-08 1959-04-02 Geigy Ag J R Improvements in and relating to n-acylated benzylamino phenols
GB1576841A (en) * 1977-01-22 1980-10-15 Beecham Group Ltd Substituted n-acyl phenylamine compounds having hypolipidaemic activity
US4243804A (en) * 1978-06-19 1981-01-06 E. R. Squibb & Sons, Inc. Heterocyclic containing amines
GB2124615B (en) * 1979-07-19 1984-07-18 Shell Int Research Heterocyclic compounds having fungicidal herbicidal and plant-growth regulating properties
JPH04145067A (ja) * 1990-10-04 1992-05-19 Hokko Chem Ind Co Ltd ヘテロ酢酸アミド誘導体および農園芸用殺菌剤
JPH0565258A (ja) * 1991-07-03 1993-03-19 Nippon Bayeragrochem Kk 酢酸アニリド誘導体および除草剤
EP0585500A1 (en) * 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl piperazineacetamides as antimuscarinic agents
TW257757B (cg-RX-API-DMAC7.html) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
DE19615262A1 (de) * 1996-04-18 1997-10-23 Bayer Ag Heteroverknüpfte Phenylglycinolamide
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
AU7467398A (en) * 1997-04-25 1998-11-24 Eli Lilly And Company Indene compounds having activity as serms
JP2000072734A (ja) * 1998-06-15 2000-03-07 Nippon Nohyaku Co Ltd アニリン誘導体
US6780883B2 (en) * 1998-11-05 2004-08-24 Warner-Lambert Company Amide inhibitors of microsomal triglyceride transfer protein
IL144717A0 (en) 1999-02-24 2002-06-30 Hoffmann La Roche Phenyl-and pyridinyl derivatives
IL144851A0 (en) * 1999-02-24 2002-06-30 Hoffmann La Roche 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
EP1035115B1 (en) 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
CN1342144A (zh) * 1999-03-04 2002-03-27 美国家用产品公司 用作雌激素药物的n-取代的苯甲酰基吲哚类化合物
US6511980B2 (en) * 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists

Similar Documents

Publication Publication Date Title
KR102110566B1 (ko) 안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법
EP1747210B1 (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
KR20200035435A (ko) 안드로겐 수용체의 표적 분해용 화합물 및 방법
JP2016509591A5 (cg-RX-API-DMAC7.html)
RU97103207A (ru) Арилтиосоединения в качестве антибактериальных и противовирусных средств
RU2009140465A (ru) Имидазохинолины с иммуномодулирующими свойствами
JP2008504276A5 (cg-RX-API-DMAC7.html)
RU95118133A (ru) Гетероциклические соединения, способы их получения и фармацевтическая композиция
RU2006116889A (ru) Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии
CN105130855A (zh) 二酰基化的羟基胺衍生物及其用途
JP2006501295A5 (cg-RX-API-DMAC7.html)
WO2001051456A2 (en) Antibacterial agents
JP2015517981A5 (cg-RX-API-DMAC7.html)
JP2013525293A5 (cg-RX-API-DMAC7.html)
JP2006524222A5 (cg-RX-API-DMAC7.html)
RU2001126579A (ru) Органические соединения
JP2008502614A5 (cg-RX-API-DMAC7.html)
AR069920A1 (es) Inhibidores de acetil coenzima a carboxilasa y usos en tratamientos de obesidad y diabetes mellitus
JP2023504542A5 (cg-RX-API-DMAC7.html)
RU2000131184A (ru) Соединения, обладающие свойствами, способствующими выделению гормона роста
JP2013509376A5 (cg-RX-API-DMAC7.html)
SK13832002A3 (sk) Pyrolidínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
JP2007528420A (ja) 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト
HRP20161260T1 (hr) Derivati (r)-arilkilamina i farmaceutski pripravci koji ih sadrže
JP2006522797A5 (cg-RX-API-DMAC7.html)